These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16260900)

  • 1. Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions.
    Titanji K; Chiodi F; Bellocco R; Schepis D; Osorio L; Tassandin C; Tambussi G; Grutzmeier S; Lopalco L; De Milito A
    AIDS; 2005 Nov; 19(17):1947-55. PubMed ID: 16260900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of memory (CD27) B lymphocytes in HIV-1 infection.
    De Milito A; Mörch C; Sönnerborg A; Chiodi F
    AIDS; 2001 May; 15(8):957-64. PubMed ID: 11399977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
    Plana M; García F; Gallart T; Tortajada C; Soriano A; Palou E; Maleno MJ; Barceló JJ; Vidal C; Cruceta A; Miró JM; Gatell JM
    AIDS; 2000 Sep; 14(13):1921-33. PubMed ID: 10997396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection.
    Kaufmann GR; Zaunders JJ; Cunningham P; Kelleher AD; Grey P; Smith D; Carr A; Cooper DA
    AIDS; 2000 Dec; 14(17):2643-51. PubMed ID: 11125882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial Effects of cART Initiated during Primary and Chronic HIV-1 Infection on Immunoglobulin-Expression of Memory B-Cell Subsets.
    Pogliaghi M; Ripa M; Pensieroso S; Tolazzi M; Chiappetta S; Nozza S; Lazzarin A; Tambussi G; Scarlatti G
    PLoS One; 2015; 10(10):e0140435. PubMed ID: 26474181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concerted effect of lymphopenia, viraemia and T-cell activation on Fas expression of peripheral B cells in HIV-1-infected patients.
    Rethi B; Sammicheli S; Amu S; Pensieroso S; Hejdeman B; Schepis D; Thang PH; Chiodi F
    AIDS; 2013 Jan; 27(2):155-62. PubMed ID: 23238551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous and anti-Fas-induced apoptosis in lymphocytes from HIV-infected patients undergoing highly active anti-retroviral therapy.
    Grelli S; Campagna S; Lichtner M; Ricci G; Vella S; Vullo V; Montella F; Di Fabio S; Favalli C; Mastino A; Macchi B
    AIDS; 2000 May; 14(8):939-49. PubMed ID: 10853975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of peripheral HIV-1-specific memory B cells in patients untreated or receiving highly active antiretroviral therapy.
    Fondere JM; Huguet MF; Yssel H; Baillat V; Reynes J; van de Perre P; Vendrell JP
    AIDS; 2003 Nov; 17(16):2323-30. PubMed ID: 14571183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection.
    De Milito A; Nilsson A; Titanji K; Thorstensson R; Reizenstein E; Narita M; Grutzmeier S; Sönnerborg A; Chiodi F
    Blood; 2004 Mar; 103(6):2180-6. PubMed ID: 14604962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection.
    Tilling R; Kinloch S; Goh LE; Cooper D; Perrin L; Lampe F; Zaunders J; Hoen B; Tsoukas C; Andersson J; Janossy G;
    AIDS; 2002 Mar; 16(4):589-96. PubMed ID: 11873002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of antiretroviral regimes in HIV-1 patients in reducing immune activation.
    Jiménez A; Molero L; Jiménez A; Castañón S; Subirá D; De Górgolas M; Fedz-Guerrero M; García R
    Immunology; 2002 May; 106(1):80-6. PubMed ID: 11972635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Antiretroviral Therapy on the Memory and Activation Profiles of B Cells in HIV-Infected African Women.
    Tanko RF; Soares AP; Müller TL; Garrett NJ; Samsunder N; Abdool Karim Q; Abdool Karim SS; Riou C; Burgers WA
    J Immunol; 2017 Feb; 198(3):1220-1228. PubMed ID: 28039305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of control of T cell apoptosis under HAART. Influence of therapy regimen in vivo and in vitro.
    de Oliveira Pinto LM; Lecoeur H; Ledru E; Rapp C; Patey O; Gougeon ML
    AIDS; 2002 Feb; 16(3):329-39. PubMed ID: 11834943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central memory CD4 T cells are associated with incomplete restoration of the CD4 T cell pool after treatment-induced long-term undetectable HIV viraemia.
    Rallón N; Sempere-Ortells JM; Soriano V; Benito JM
    J Antimicrob Chemother; 2013 Nov; 68(11):2616-25. PubMed ID: 23833186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of immune reconstitution in antiretroviral drug-experienced patients with advanced HIV disease.
    Landay AL; Bettendorf D; Chan E; Spritzler J; Schmitz JL; Bucy RP; Gonzalez CJ; Schnizlein-Bick CT; Evans T; Squires KE; Phair JP
    AIDS Res Hum Retroviruses; 2002 Jan; 18(2):95-102. PubMed ID: 11839142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma.
    Powles T; Imami N; Nelson M; Gazzard BG; Bower M
    AIDS; 2002 Mar; 16(4):531-6. PubMed ID: 11872995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmacytoid dendritic cells mediate synergistic effects of HIV and lipopolysaccharide on CD27+ IgD- memory B cell apoptosis.
    Zhang L; Luo Z; Sieg SF; Funderburg NT; Yu X; Fu P; Wu H; Jiao Y; Gao Y; Greenspan NS; Harding CV; Kilby JM; Li Z; Lederman MM; Jiang W
    J Virol; 2014 Oct; 88(19):11430-41. PubMed ID: 25056888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naive CD4+ T lymphocytes express high levels of Bcl-2 after highly active antiretroviral therapy for HIV infection.
    Airò P; Torti C; Uccelli MC; Malacarne F; Palvarini L; Carosi G; Castelli F
    AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1805-7. PubMed ID: 11118066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and immunological benefits from highly active antiretroviral therapy in spite of limited viral load reduction in HIV type 1 infection.
    Hejdeman B; Lenkei R; Leandersson AC; Hultström AL; Wahren B; Sandström E; Bratt G
    AIDS Res Hum Retroviruses; 2001 Mar; 17(4):277-86. PubMed ID: 11242515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.